Amgen 2011 Annual Report Download - page 78

Download and view the complete annual report

Please find page 78 of the 2011 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 184

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184

Item 2. PROPERTIES
The following table summarizes our significant properties and their primary functions as of December 31,
2011. For additional information regarding manufacturing initiatives, see Item 1. Business — Manufacturing,
Distribution and Raw Materials.
Location
Owned
Leased
Neulasta®
NEUPOGEN®
Enbrel®
Aranesp®
epoetin alfa
Other products
Clinical
United States:
Thousand Oaks, California.......................................................... 35 6 B
F
bbbbb
San Francisco, California.............................................................
.
- 5
bb
Boulder, Colorado........................................................................
.
2 2 BB
bb
Longmont, Colorado.................................................................... 6 1 BB
bb
Washington, D.C........................................................................... - 1
bb
Louisville, Kentucky....................................................................
.
1 -
bb
Cambridge, Massachusetts.......................................................... 1 -
b
Woburn, Massachusetts...............................................................
.
- 2 B
F
bb
West Greenwich, Rhode Island .................................................. 6 - BB
bb
Bothell, Washington..................................................................... 3 1
bb
Seattle, Washington ..................................................................... 6 -
bb
Other U.S. cities ............................................................................ - 5
bb
Outside United States:
Australia........................................................................................
.
- 2
bb
Brazil..............................................................................................
.
1 5 F
bbbb
Canada...........................................................................................
.
- 3
bbb
Ireland............................................................................................
.
8 2 F
bbb
J
apan............................................................................................... - 1
bb
Netherlands................................................................................... 8 - F1 F1 F1 F1 F1
bbbb
Puerto Rico....................................................................................
.
21 - B
F
B
FF
B
F
B1
FF
B
F
bb
Switzerland.................................................................................... - 2
bb
United Kingdom........................................................................... 1 4
bbb
Other countries.............................................................................
.
- 30
bb
F1—Finish only
B—Bulk manufacturing
F—Formulation, fill and finish
Number of
spaces or
buildings
Other functions
Commercial
Administrative
Research and/or development
Sales and marketing
Warehouse
Distribution center
Manufacturing
B1—Bulk manufacturing (purification only)
62